Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Evolving Role of Subcutaneous Therapies in NSCLC : Episode 11
Impact of SC Formulations on Pharmacy Operations
Panelists discuss how SC formulations streamline pharmacy workflows and optimize oncology practice efficiency.
EP: 1.Understanding EGFR Mutations and First-Line Treatment
EP: 2.Overcoming Resistance Mechanisms and Addressing Unmet Needs
EP: 3.Impact of Recent Approvals and Novel Mechanisms
EP: 4.CNS Penetration and Efficacy of Emerging Therapies
EP: 5.Managing Adverse Events and Integrating Amivantamab Plus Lazertinib
EP: 6.Sequencing Therapies and Using the Most Effective Options First
EP: 7.The Value of Subcutaneous Therapy for Patients
EP: 8.FDA Approvals, Patient Selection, and SC Amivantamab
EP: 9.Counseling Patients on IV vs SC Administration
EP: 10.Improving Adherence and Transitioning to SC Therapy
Now Viewing
EP: 11.Impact of SC Formulations on Pharmacy Operations
EP: 12.Barriers to Adoption of SC Therapies
Panelists discuss how subcutaneous (SC) formulations affect pharmacy operations, workflow, and staffing models in oncology. They note reduced compounding requirements, improved efficiency in drug preparation, and faster administration times. The discussion highlights that successful integration requires collaboration across pharmacy, nursing, and clinic management. SC therapies are recognized as a means of improving capacity and throughput while maintaining quality and safety standards.
Related Videos
Related Content
